Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Holding GB:CYBO?
Track your performance easily
GB:CYBO Price & Analysis
CYBO ETF Chart & Stats
Day’s Range― - ―
52-Week Range$16.35 - $22.48
Previous Close$21.22
VolumeN/A
Average Volume (3M)322.00
AUM6.31M
NAV20.98
Expense Ratio0.55%
Holdings Count26
Beta0.80
Inception DateDec 02, 2022
Next Dividend Ex-DateN/A
Dividend YieldN/A
Shares OutstandingN/A
Standard Deviation0.07
10 Day Avg. Volume3
30 Day Avg. Volume322
Alpha-0.00263
VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) Fund Flow Chart
VanEck Bionic Engineering UCITS ETF Accum -A- USD (CYBO) 1 year Net Flows: $612K
CYBO ETF News
PremiumMarket News
SPY ETF Update, 9/20/2024 
PremiumCompany Announcements
Smith & Nephew Executives Buy Shares as Pay
PremiumMarket News
VOO ETF Update, 9/19/2024 CYBO ETF FAQ
What was GB:CYBO’s price range in the past 12 months?
GB:CYBO lowest ETF price was $16.35 and its highest was $22.48 in the past 12 months.
What is the AUM of GB:CYBO?
As of Sep 18, 2024 The AUM of GB:CYBO is 6.31M.
Is GB:CYBO overvalued?
According to Wall Street analysts GB:CYBO’s price is currently Undervalued.
Does GB:CYBO pay dividends?
GB:CYBO does not currently pay dividends.
How many shares outstanding does GB:CYBO have?
Currently, no data Available
Which hedge fund is a major shareholder of GB:CYBO?
Currently, no hedge funds are holding shares in GB:CYBO
CYBO ETF Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Learn more about TipRanks Smart Score
For ETFs, the calculations for the Smart Score, Analyst Consensus, Price Target, Blogger Sentiment, News Sentiment and Insider Transactions are based on the weighted average of the ETF's holdings and some additional factors. Hedge Fund Trend, Crowd Wisdom and Technicals are based on the actual ETF ticker.
Top 10 Holdings
Medtronic
11.17%
Stryker Corp
10.87%
Edwards Lifesciences Corp.
8.02%
Zimmer Biomet Holdings
6.18%
Dexcom
6.18%
Sonova Holding
5.93%
Straumann Holding
5.71%
Insulet
4.58%
Cochlear Limited
3.95%
Smith & Nephew Snats
3.83%
Total66.42%
ETF Description
VanEck Bionic Engineering UCITS ETF Accum -A- USD
Lobjectif dinvestissement du Fonds est de reproduire, avant les frais et les dpenses, l'indice MVIS Global Bionic Healthcare ESG (l' Indice ).